Myocardial and cardiomyocyte stress resilience is enhanced in aromatase-deficient female mouse hearts through CaMKIIδ activation

Endocrinology (United States)

Volumn 156, Issue 4, 2015, Pages 1429-1440

  Bell, James R ^a   Bernasochi, Gabriel B ^a   Wollermann, Amanda C ^a   Raaijmakers, Antonia J A ^a   Boon, Wah Chin ^a   Simpson, Evan R ^b   Curl, Claire L ^a   Mellor, Kimberley M ^a,c   Delbridge, Lea M D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 11 DELTA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; GLUCOSE TRANSPORTER 1; UNCLASSIFIED DRUG; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AROMATASE DEFICIENCY; ARTICLE; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORT; HEART MUSCLE CELL; INTRAABDOMINAL FAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; UPREGULATION; ANIMAL; BODY WEIGHT; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REPERFUSION INJURY; SARCOPLASMIC RETICULUM;

ANIMALS; AROMATASE; BODY WEIGHT; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; SARCOPLASMIC RETICULUM;

EID: 84926431716     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1700     Document Type: Article

References (48)

1. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136(2):205-212.
2. Vaccarino V. Ischemic heart disease in women: many questions, few facts. Circ Cardiovasc Quality Outcomes. 2010;3(2):111-115.
3. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288(1):49-57.
4. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
5. Bell JR, Porrello ER, Huggins CE, Harrap SB, Delbridge LM. The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2008;294(4):H1514-H1522.
6. Brown DA, Lynch JM, Armstrong CJ, et al. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol. 2005;564(Pt 2):619-630.
7. Cross HR, Lu L, Steenbergen C, Philipson KD, Murphy E. Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res. 1998;83(12):1215-1223.
8. Cross HR, Murphy E, Steenbergen C. Ca(2+) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. AmJ Physiol Heart Circ Physiol. 2002;283(2):H481-H489.
9. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor β mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol. 2005;38(2):289-297.
10. Kolodgie FD, Farb A, Litovsky SH, et al. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol. 1997;29(9):2403-2414.
11. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res. 2010;106(11):1681-1691.
12. Liu H, Pedram A, Kim JK. Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β. Cardiovasc Res. 2011;89(1):119-128.
13. Ross JL, Howlett SE. Age and ovariectomy abolish beneficial effects of female sex on rat ventricular myocytes exposed to simulated ischemia and reperfusion. PloS One. 2012;7(6):e38425.
14. Wang M, Crisostomo PR, Markel T, Wang Y, Lillemoe KD, Meldrum DR. Estrogen receptor β mediates acute myocardial protection following ischemia. Surgery. 2008;144(2):233-238.
15. Wang M, Wang Y, Weil B, et al. Estrogen receptor β mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol. 2009;296(4):R972-R978.
16. Willems L, Zatta A, Holmgren K, Ashton KJ, Headrick JP. Age-related changes in ischemic tolerance in male and female mouse hearts. J Mol Cell Cardiol. 2005;38(2):245-256.
17. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol. 2000;279(6):H2766-H2775.
18. Bell JR, Bernasochi GB, Varma U, Raaijmakers AJ, Delbridge LM. Sex and sex hormones in cardiac stress - mechanistic insights. J Steroid Biochem Mol Biol. 2013;137:124-135.
19. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003;86(3-5):225-230.
20. Bell JR, Mellor KM, Wollermann AC, et al. Aromatase deficiency confers paradoxical postischemic cardioprotection. Endocrinology. 2011;152(12):4937-4947.
21. Beitelshees AL, Johnson JA, Hames ML, et al. Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner. PloS One. 2010;5(12):e15180.
22. Bell JR, Bernasochi GB, Varma U, et al. Aromatase transgenic upregulation modulates basal cardiac performance and the response to ischemic stress in male mice. AmJ Physiol Heart Circ Physiol. 2014;306(9):H1265-H1274.
23. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88(2):581-609.
24. Bell JR, Mellor KM, Wollermann AC, Delbridge LM. Cardiac ischaemic stress: cardiomyocyte Ca(2)(+), sex and sex steroids. Clin Exp Pharmacol Physiol. 2011;38(10):717-723.
25. Farrell SR, Ross JL, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling in rat ventricular myocytes. Am J Physiol Heart Circ Physiol. 2010;299(1):H36-H45.
26. Curl CL, Wendt IR, Canny BJ, Kotsanas G. Effects of ovariectomy and 17β-oestradiol replacement on [Ca2+]i in female rat cardiac myocytes. Clin Exp Pharmacol Physiol. 2003;30(7):489-494.
27. Curl CL, Wendt IR, Kotsanas G. Effects of gender on intracellular [Ca2+] in rat cardiomyocytes. Pflugers Archiv. 2001;441(5):709-716.
28. Fares E, Parks RJ, Macdonald JK, Egar JM, Howlett SE. Ovariectomy enhances SR Ca(2)(+) release and increases Ca(2)(+) spark amplitudes in isolated ventricular myocytes. J Mol Cell Cardiol. 2012;52(1):32-42.
29. Curl CL, Delbridge LM, Canny BJ, Wendt IR. Testosterone modulates cardiomyocyte Ca(2+) handling and contractile function. Physiol Res. 2009;58(2):293-297.
30. Maier LS, Bers DM. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res. 2007;73(4):631-640.
31. Bell JR, Vila-Petroff M, Delbridge LM. CaMKII-dependent responses to ischemia and reperfusion challenges in the heart. Front Pharmacol. 2014;5:96.
32. Di Carlo MN, Said M, Ling H, et al. CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury. J Mol Cell Cardiol. 2014;74C:274-283.
33. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA. 1998;95(12):6965-6970.
34. Mellor KM, Bell JR, Wendt IR, Davidoff AJ, Ritchie RH, Delbridge LM. Fructose modulates cardiomyocyte excitation-contraction coupling and Ca(2)(+) handling in vitro. PloS One. 2011;6(9):e25204.
35. Satoh H, Delbridge LM, Blatter LA, Bers DM. Surface:volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects. Biophys J. 1996;70(3):1494-1504.
36. Bell JR, Kennington E, Fuller W, et al. Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity. Am J Physiol Heart Circ Physiol. 2008;294(2):H613-H621.
37. Mellor KM, Bell JR, Young MJ, Ritchie RH, Delbridge LM. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol. 2011;50(6):1035-1043.
38. Huangda W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
39. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1-13.
40. Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA. 2000;97(23):12735-12740.
41. Curl CL, Bell JR, Delbridge LM. 'Gain'-ful insight into the cardiomyocyte Ca(2)(+) seX factor. J Mol Cell Cardiol. 2012;52(1):7-9.
42. Bell JR, Curl CL, Ip WT, Delbridge LM. Ca2+/calmodulin-dependent protein kinase inhibition suppresses post-ischemic arrhythmogenesis and mediates sinus bradycardic recovery in reperfusion. Int J Cardiol. 2012;159(2):112-118.
43. Vila-Petroff M, Salas MA, Said M, et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc Res. 2007;73(4):689-698.
44. Bell JR, Erickson JR, Delbridge LM. Ca(2+)/calmodulin dependent kinase II: a critical mediator in determining reperfusion outcomes in the heart? Clin Exp Pharmacol Physiol. 2014;41(11):940-946.
45. Said M, Vittone L, Mundina-Weilenmann C, Ferrero P, Kranias EG, Mattiazzi A. Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants. Am J Physiol Heart Circ Physiol. 2003;285(3):H1198-H1205.
46. Vittone L, Mundina-Weilenmann C, Said M, Ferrero P, Mattiazzi A. Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways. J Mol Cell Cardiol. 2002;34(1):39-50.
47. Bell JR, Raaijmakers AJ, Curl CL, et al. Cardiac CaMKIIδ splice variants exhibit target signaling specificity and confer sex-selective arrhythmogenic actions in the ischemic-reperfused heart. Int J Cardiol. 2014;181C:288-296.
48. Jazbutyte V, Stumpner J, Redel A, et al. Aromatase inhibition attenuates desflurane-induced preconditioning against acute myocardial infarction in male mouse heart in vivo. PloS One. 2012;7(8):e42032.